Magenta therapeutics and dianthus therapeutics announce merger agreement

Merger to create nasdaq-listed, clinical-stage biotechnology company focused on advancing dianthus' portfolio of next-generation antibody complement therapeutics

DNTH Ratings Summary

DNTH Quant Ranking